ArticleArthritis research & therapy2026
Subclinical atherosclerosis in rheumatoid arthritis is driven by MicroRNA polymorphisms and NETosis.
Article in Arthritis research & therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Atherosclerosis in Rheumatoid Arthritis: The Role of NETs and Management.Journal of inflammation research · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundRheumatoid arthritis (RA) is associated with increased cardiovascular disease (CVD) risk, not fully explained by traditional risk factors. Neutrophil extracellular traps (NETs) and regulatory microRNA polymorphisms (miR-SNPs) may contribute to RA-related atherosclerosis through thromboinflammatory mechanisms.
objectivesTo investigate whether miR-SNPs (rs2431697, rs3746444, rs11614913) are associated with subclinical atherosclerosis in RA, and whether NETosis mediates this relationship.
methodsWe genotyped 620 RA patients and 359 healthy controls. Carotid intima-media thickness (CIMT) was assessed in 65 RA patients and 75 controls. Circulating NETosis markers (cfDNA and citH3–DNA) were quantified. Logistic regression models evaluated the association between miR-SNPs and pathological CIMT (pCIMT), accounting for RA status and cardiovascular risk factors.
resultsThe rs11614913 C allele was associated with RA susceptibility. pCIMT was significantly more frequent in RA patients than in controls (75.4% vs. 45.3%, p < 0.001). RA-specific associations were observed between pCIMT and both rs2431697 and rs3746444. The rs2431697 T allele was also associated with increased citH3–DNA levels, suggesting enhanced NETosis.
conclusionsmiR-SNPs rs2431697 and rs3746444 are associated with subclinical atherosclerosis in RA and, in the case of rs2431697, preliminary results suggest that NETosis could be an underlying mechanism. These findings support their potential as biomarkers and therapeutic targets to reduce CVD risk in RA.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.